Soligenix, Inc. Files 8-K: Shareholder Vote, Reg FD, Financials
Ticker: SNGX · Form: 8-K · Filed: May 24, 2024 · CIK: 812796
| Field | Detail |
|---|---|
| Company | Soligenix, Inc. (SNGX) |
| Form Type | 8-K |
| Filed Date | May 24, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, sec-filing
Related Tickers: SOLI
TL;DR
SOLI filed an 8-K covering shareholder votes, Reg FD, and financials. Stay tuned.
AI Summary
On May 23, 2024, Soligenix, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders, Regulation FD disclosures, and financial statements. The filing also includes information about the company's incorporation in Delaware and its principal business address in Princeton, NJ.
Why It Matters
This 8-K filing provides crucial updates on Soligenix, Inc.'s corporate governance and financial reporting, informing investors about key decisions and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Numbers
- 001-14778 — SEC File Number (Identifies Soligenix, Inc.'s filing with the SEC.)
- 41-1505029 — IRS Employer Identification Number (Tax identification number for Soligenix, Inc.)
Key Players & Entities
- Soligenix, Inc. (company) — Filer of the 8-K report
- May 23, 2024 (date) — Date of the earliest event reported
- 001-14778 (other) — Commission File Number for Soligenix, Inc.
- 41-1505029 (other) — I.R.S. Employer Identification Number for Soligenix, Inc.
- 29 Emmons Drive, Suite B-10, Princeton, NJ (location) — Business address of Soligenix, Inc.
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not elaborated in the provided text.
What is the significance of the Regulation FD Disclosure?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, preventing selective disclosure.
What financial statements are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in the provided text.
When was Soligenix, Inc. incorporated?
Soligenix, Inc. was incorporated in Delaware, as indicated by the filing.
What are the former names of Soligenix, Inc. mentioned in the filing?
The filing mentions former names including DOR BIOPHARMA INC (name change 20020329), ENDOREX CORP (name change 19960916), and IMMUNOTHERAPEUTICS INC (name change 19920703).
Filing Stats: 599 words · 2 min read · ~2 pages · Grade level 9.1 · Accepted 2024-05-24 16:05:27
Filing Documents
- sngx-20240523x8k.htm (8-K) — 35KB
- sngx-20240523xex99d1.htm (EX-99.1) — 25KB
- sngx-20240523xex99d1001.jpg (GRAPHIC) — 14KB
- 0001558370-24-008642.txt ( ) — 240KB
- sngx-20240523.xsd (EX-101.SCH) — 4KB
- sngx-20240523_def.xml (EX-101.DEF) — 3KB
- sngx-20240523_lab.xml (EX-101.LAB) — 12KB
- sngx-20240523_pre.xml (EX-101.PRE) — 10KB
- sngx-20240523x8k_htm.xml (XML) — 5KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On May 23, 2024, Soligenix, Inc. (the "Company") convened its 2024 Annual Meeting of Stockholders. At the Annual Meeting, there was not a sufficient number of shares of the Company's common stock present or represented by proxy in order to a constitute quorum. The Company adjourned the Annual Meeting, without transaction any business. The Annual Meeting will resume at 9:00 a.m. Eastern Daylight Time on May 30, 2024 and will continue to be held virtually via live audio-only webcast at www.virtualshareholdermeeting.com/sngx2024 .
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On May 24, 2024, the Company issued a press release announcing the convening and adjournment of the Annual Meeting and the information for the reconvened Annual Meeting. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information furnished in this Item 7.01 shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "1934 Act"), and shall not be deemed incorporated by reference in any filing with the Securities and Exchange Commission, whether or not filed under the Securities Act of 1933, as amended, or the 1934 Act, regardless of any general incorporation language in such document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated May 24, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Soligenix, Inc. May 24, 2024 By: /s/ Christopher J. Schaber Christopher J. Schaber, Ph.D. President and Chief Executive Officer (Principal Executive Officer) 3